S. Elliman

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Steven Elliman, Steve Elliman, S.j. Elliman, Steve J Elliman, Stephen Joseph Elliman, Stephen J. Elliman, S. Elliman, Stephen Elliman, S. J. Elliman, Stephen J Elliman, Steve J. Elliman
Publication record
54 papers · 1,977 citations · H-index 19

PAPERS

Mesenchymal Stem/Stromal Cells: THE EFFECT OF MACROMOLECULAR CROWDING ON DECELLULARIZED GRAFT MEDIATED MESENCHYMAL STROMAL CELL DELIVERY FOR TREATMENT OF DIABETIC WOUNDS
20230 citationsauthor #3
Immunotherapy: INITIAL CO-CULTURE WITH CLINICAL-GRADE UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELL ENHANCES EX VIVO HUMAN REGULATORY T CELL EXPANSION
20230 citationsauthor #6
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
202355 citationsauthor #25
Carrageenan as a macromolecular crowding agent in human umbilical cord derived mesenchymal stromal cell culture.
202320 citationsauthor #2
Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model
202313 citationsauthor #7
Mesenchymal Stem/Stromal Cells: MACROMOLECULAR CROWDING ENHANCES EXTRACELLULAR MATRIX DEPOSITION OF MESENCHYMAL STROMAL CELLS GROWN ON SCAFFOLD
20220 citationsauthor #2
Mesenchymal Stem/Stromal Cells: INTERIM REPORT FROM THE NEPHSTROM MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-1B CLINICAL TRIAL OF A NOVEL MESENCHYMAL STROMAL CELL THERAPY IN PROGRESSIVE DIABETIC KIDNEY DISEASE
20220 citationsauthor #20
Mesenchymal Stem/Stromal Cells: ANTI-CD362+ SELECTED HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELLS AMELIORATE SKELETAL MUSCLE DAMAGE INDUCED BY ISCHEMIA
20220 citationsauthor #7
Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis
20226 citationsauthor #4
Mesenchymal Stem/Stromal Cells: A NOVEL, MULTI-SITE GMP PROTOCOL TO MANUFACTURE PROSPECTIVELY-ISOLATED, ALLOGENEIC BONE MARROW MSCS FOR A PHASE 1B CLINICAL TRIAL IN PROGRESSIVE DIABETIC KIDNEY DISEASE
20220 citationsauthor #22
Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice
20213 citationsauthor #8
Comparison of Single and Repeated Dosing of Anti-Inflammatory Human Umbilical Cord Mesenchymal Stromal Cells in a Mouse Model of Polymicrobial Sepsis
202115 citationsauthor #12
In vitro optimization of macromolecular crowding conditions in human umbilical cord derived mesenchymal stromal cell culture
20210 citationsauthor #2
Macromolecular crowding enhances and accelerates extracellular matrix deposition in human umbilical cord derived mesenchymal stem cell cultures
20200 citationsauthor #2
Umbilical Cord-Derived CD362+ Mesenchymal Stromal Cells Attenuate Polymicrobial Sepsis Induced by Caecal Ligation and Puncture
202016 citationsauthor #5
Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion
202023 citationsauthor #10
Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: impact of dose regimen, passage, cryopreservation, and antibiotic therapy
202030 citationsauthor #7
MALDI‐IMS as a Tool to Determine the Myocardial Response to Syndecan‐2‐Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy
20205 citationsauthor #7
THU-079-Study of anti-fibrotic activity of human umbilical-cord tissue-derived mesenchymal stromal cells during fibrogenesis or resolution in murine models of liver fibrosis
20190 citationsauthor #8
Hypoxia Activates the PTHrP –MEF2C Pathway to Attenuate Hypertrophy in Mesenchymal Stem Cell Derived Cartilage
201924 citationsauthor #4
Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells
2018424 citationsauthor #9
Monocytic Cells Phagocytose Therapeutic Mesenchymal Stem Cells, which Induces Polarization, Relocation and Immune Regulation
20180 citationsauthor #9
Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat
201824 citationsauthor #7
Sub-cutaneously delivered mesenchymal stromal cells and down-regulation of activated vascular endothelium – a novel, clinically ready, therapeutic approach to treating cholestatic liver disease
20180 citationsauthor #9
Syndecan-2–positive, Bone Marrow–derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats
201845 citationsauthor #6
Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expansion.
201828 citationsauthor #7
Cd39 stromal stem cells methods of isolation and use
20180 citationsauthor #1
Aging of bone marrow- and umbilical cord-derived mesenchymal stromal cells during expansion.
201779 citationsauthor #7
Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease
20172 citationsauthor #11
288 – Angiogenic assessment of ORBCELTM, a novel stromal cell population for treating Critical Limb Ischaemia (CLI)
20170 citationsauthor #5
223 - Impact of culture expansion and inflammatory cytokine challenge on DNA methylation profiles in MSC
20170 citationsauthor #5
In vivo tracking of live and dead mesenchymal stromal cells
20173 citationsauthor #4
Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease
201796 citationsauthor #11
62 - Ageing of bone marrow and umbilical cord derived MSC during culture expansion
20173 citationsauthor #6
Effect of fetal bovine serum in culture media on MS analysis of mesenchymal stromal cells secretome
201629 citationsauthor #7
3D biodistribution of pre-treated MSC in mouse model of liver disease using CryoViz™
20161 citationsauthor #7
P48 HUMAN CD362+ MESENCHYMAL STROMAL CELL THERAPY FOR DIABETIC KIDNEY DISEASE IN LEPR DB/DB MICE
20160 citationsauthor #3
Cd362+ Human Mesenchymal Stromal Cells Reduce Hepatic Inflammation and Induce M2 Macrophage Polarisation in Murine Models of Primary Sclerosing Cholangitis
20162 citationsauthor #13
A unique population of stromal stem cells (SSCs) protect against neurovascular dysfunction during diabetic retinopathy
20160 citationsauthor #3
CD362+ stromal stem cells(SSCs) stabilize vascular networks through differentiation into pericyte-like cells
20160 citationsauthor #4
Therapeutic Efficacy of Human Mesenchymal Stromal Cells in the Repair of Established Ventilator-induced Lung Injury in the Rat
201561 citationsauthor #5
CD362+ stromal stem cells (SSCs) promote revascularisation of the retina in a paracrine manner
20150 citationsauthor #6
Topical application of CD362+ human mesenchymal stem cells (cyndacel-M) seeded in Excellagen scaffold augments wound healing and increases angiogenesis in a diabetic rabbit ulcer model
20151 citationsauthor #7
Vasoreparative potential of a unique population of stromal stem cells (SSCs) in ischaemic retina.
20150 citationsauthor #4
Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat
2015191 citationsauthor #4
From isolation to implantation: a concise review of mesenchymal stem cell therapy in bone fracture repair
20143 citationsauthor #2
From isolation to implantation: a concise review of mesenchymal stem cell therapy in bone fracture repair
201480 citationsauthor #2
Heat shock protein 90 (HSP90) inhibitors activate the heat shock factor 1 (HSF1) stress response pathway and improve glucose regulation in diabetic mice.
201359 citationsauthor #4
Dynamic resolution of functionally related gene sets in response to acute heat stress
200714 citationsauthor #5
Resveratrol inhibits firefly luciferase.
200663 citationsauthor #3
Adult Tissue-specific Expression of a Dppa3-derived Retrogene Represents a Postnatal Transcript of Pluripotent Cell Origin*
200620 citationsauthor #1
Extending the lineage potential of human mesenchymal stem cells
20060 citationsauthor #1
Imatinib mesylate (Gleevec) protects against streptozotocin‐induced diabetes and islet cell death in vitro
200650 citationsauthor #3
Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma
2004485 citationsauthor #7

TIMELINE

2004 485 citations

2006 133 citations

2007 14 citations

2013 59 citations

2014 83 citations

2015 253 citations

2016 32 citations

2017 183 citations

2018 521 citations

2019 24 citations

2020 74 citations

2021 18 citations

2022 6 citations

2023 88 citations

COAUTHOR MAP

CONCEPT FOOTPRINT